The panel discussion on Overseas Listing – Insights for Corporates took place on Monday, 23 November 2020. The second conversation of the webinar series was focused on high-growth mid-market companies that have explored the overseas listing opportunity or are interested in knowing more about overseas listing.

Key Highlights

  • Companies with global aspirations and well-defined strategies for growth should consider listing overseas. Healthcare, pharma, cleantech and biotech companies will be among the early drivers of overseas listing.
  • Understanding the process and choosing the right partners is key to achieving a successful listing. Advisors provide the right direction in terms of roadshows, due diligence checks and regulatory compliances.
  • While overseas listing provides flexibility, there are strict governance and compliance requirements to be adhered to.
  • Knowing your investors and the market for your business are crucial factors for choosing the exchange for listing.


vishesh-chandiok.png keshav-murugesh.png robert-mccooey.png gokul-mani.png bharat-reddy.png
Vishesh C. Chandiok
Grant Thornton Bharat
Keshav R. Murugesh (keynote)
Group CEO
WNS Global Services, Past Chairman, NASSCOM
Robert H. McCooey, Jr.
Chairman, Asia Pacific
Gokul Mani
Head of Primary Markets – Middle East, Africa & India
London Stock Exchange (LSE)
Bharat K. Reddy
JPMorgan Chase & Co.
francis-giglio.png rajiv-gupta.png sanjay-banthia.png raja-lahiri.png prashant-mehra.png
Francis Giglio
MD & Head, Depositary Receipts – APAC, Hong Kong
BNY Mellon
Rajiv Gupta
Latham & Watkins LLP, Singapore
Sanjay Banthia
Chartered Accountant,
Raja Lahiri
Grant Thornton Bharat
Prashant Mehra (moderator)
Grant Thornton Bharat

If you are interested in exploring the overseas listing opportunity for your organisation, or have any questions, please email our expert at Raja.Lahiri@IN.GT.COM

Date & Time

Date: Friday 06 November, 2020
Time: 17:00 - 19:00 Hrs IST

  • To know more about the webinar, please write to us at
Tel: +91 11 4952 7400 Contact: